Only half (53%) of online advertisements for medicines are correctly categorized by consumers as legitimate or illicit. This result emerged from project CAPSULE, conducted by Transcrime, Joint ...

Positive Agenzia Italiana del Farmaco (AIFA) decision provides reimbursed access to the first medicine available for the treatment of all types of PFIC, a rare and devastating disorder that ...

The therapy has been available in Italy since August 2023 under a determination by the Italian Medicines Agency (AIFA), which ...

Date range: 1 December 2022 - 30 November 2023 No articles found. Italian Medicines Agency (AIFA) did not contribute to any primary research papers from Nature Index journals in the current 12 ...

NEUROBIS is one of the few randomised, placebo controlled, double-blind trial with a Cannabis-based medicine to be conducted at multiple sites in Italy and a study of this robust scientific nature ...

CAPSULE Project, led by Transcrime-Università Cattolica, analyzed consumer awareness towards online purchases of illicit medicines in Italy and Spain.

The Italian Medicines Agency is ready to evaluate the reimbursement of new drugs against obesity, following the British model. This was announced by the president of Aifa, Robert Nisticò: 'As soon ...

In 2020, the Italian Medicines Agency made hormone replacement therapy free of charge nationwide for people who received a diagnosis of “gender dysphoria. ...

BOSTON, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma (ALBO), Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators to treat pediatric and adult liver ...

The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase II study to evaluate safety, and efficacy of an Avextra oral ...

Only half (53%) of online advertisements for medicines are correctly categorized by consumers as legitimate or illicit. This result emerged from project CAPSULE, conducted by Transcrime, Joint ...